Considering the finding that tumor cell–derived factors suppressed caspase-8 and GSDMD activation in CD4+ T cells, it will be intriguing to identify and characterize these factors in the TME, which could be potential new targets for cancer immunotherapy. The gene discussed is CD4; the disease is cancer.